Literature DB >> 27920078

Response by Li et al to Letter Regarding Article, "Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria Due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart".

Ning Li1, Brian J Hansen1, Vadim V Fedorov1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27920078      PMCID: PMC5147618          DOI: 10.1161/CIRCULATIONAHA.116.025797

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

Review 1.  Adenosine and its receptors in the heart: regulation, retaliation and adaptation.

Authors:  John P Headrick; Jason N Peart; Melissa E Reichelt; Luke J Haseler
Journal:  Biochim Biophys Acta       Date:  2010-11-19

2.  A novel association of adenosine deaminase with paroxysmal atrial fibrillation: a propensity score analysis from a case-control study.

Authors:  Liang Liu; Yong-Ming He; Cui-Fen Hu; Xin Zhao; Hai-Feng Xu; Xiang-Jun Yang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

3.  Myocardial infarction related atrial fibrillation: role of endogenous adenosine.

Authors:  B D Bertolet; J A Hill; R A Kerensky; L Belardinelli
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

4.  Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart.

Authors:  Ning Li; Thomas A Csepe; Brian J Hansen; Lidiya V Sul; Anuradha Kalyanasundaram; Stanislav O Zakharkin; Jichao Zhao; Avirup Guha; David R Van Wagoner; Ahmet Kilic; Peter J Mohler; Paul M L Janssen; Brandon J Biesiadecki; John D Hummel; Raul Weiss; Vadim V Fedorov
Journal:  Circulation       Date:  2016-07-26       Impact factor: 29.690

  4 in total
  2 in total

Review 1.  Adenosine and the Cardiovascular System: The Good and the Bad.

Authors:  Régis Guieu; Jean-Claude Deharo; Baptiste Maille; Lia Crotti; Ermino Torresani; Michele Brignole; Gianfranco Parati
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

2.  Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation.

Authors:  Mindi Zhao; Xiaoyan Liu; Xiaoxiao Bu; Yao Li; Meng Wang; Bo Zhang; Wei Sun; Chuanbao Li
Journal:  PeerJ       Date:  2022-08-09       Impact factor: 3.061

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.